1 |
2022 |
Chinese expert consensus on the nursing management of the totally implantable venous access device. |
--- |
2 |
2022 |
Persistent Left Superior Vena Cava Associated with Right Aberrant Subclavian Artery Detected during Totally Implantable Vascular Access Device Insertion. |
--- |
3 |
2022 |
Portacath Implantation in Ghana: Initial Experience at the Komfo Anokye Teaching Hospital in Kumasi. |
--- |
4 |
2022 |
Prolong the flushing and locking interval of TIVAD is feasible in COVID-19: An overview of systematic reviews. |
SRs |
5 |
2022 |
Safety of Insertion of Percutaneous Totally Implantable Central Venous Access Devices by Surgical Residents. |
ESs, IJV, SRs, SV |
6 |
2022 |
Surgical management after Oxaliplatin extravasation: A case report and literature review. |
--- |
7 |
2022 |
Transesophageal echocardiography-guided implantation of totally implantable venous access devices via the internal jugular vein: retrospective analysis of 297 cases in pediatric patients. |
IJV, TEE |
8 |
2021 |
A cluster of grapes: Right atrial masses of uncertain origin. |
CRAT |
9 |
2021 |
A prospective, randomized study assessing different modalities for flushing totally implanted vascular access device in children with malignancy. |
--- |
10 |
2021 |
A totally implantable venous access device (TIVAD) abandoned for 5 years is re-accessed normally: A case report and literature review. |
TIVADs |
11 |
2021 |
Clinical and dosimetric impact of totally implantable venous access devices in radiotherapy of supra diaphragmatic Hodgkin Lymphoma. |
3DCRT, HT, RT |
12 |
2021 |
Diagnostic error in detection of fractured and migrated totally implantable venous access device fragments and experience with percutaneous retrieval: A report of 27 cases. |
--- |
13 |
2021 |
Forty years after the first totally implantable venous access device (TIVAD) implant: the pure surgical cut-down technique only avoids immediate complications that can be fatal. |
IJV, SCV |
14 |
2021 |
Image-guided placement of totally implanted vascular access device: retrospective analysis of the clinical outcomes and associated risk factors. |
--- |
15 |
2021 |
Pinch-off syndrome from a chemoport catheter successfully managed with endovascular retrieval. |
POS |
16 |
2021 |
The effect of chemotherapy type and timing among the other factors on patency of totally implantable vascular access devices in colorectal carcinoma. |
--- |
17 |
2021 |
Totally Implantable Venous-Access Device in Maintenance Electroconvulsive Therapy: A Retrospective Case Series. |
ECT |
18 |
2020 |
Extending the interval of flushing procedures of totally implantable vascular access devices in cancer patients: It is time for a change. |
--- |
19 |
2020 |
Introduction of a specialized consultation prior to insertion of totally implantable access venous devices: Impact on cancellation rate and patient satisfaction. |
--- |
20 |
2019 |
Ultrasound-based prediction of cephalic vein cutdown success prior to totally implantable venous access device placement. |
--- |
21 |
2019 |
Ultrasound-guided totally implantable venous access device through the right innominate vein in older patients is safe and reliable. |
--- |
22 |
2019 |
Which is Better for Patients with Breast Cancer: Totally Implanted Vascular Access Devices (TIVAD) or Peripherally Inserted Central Catheter (PICC)? |
PICC |
23 |
2019 |
Which is Better for Patients with Breast Cancer: Totally Implanted Vascular Access Devices (TIVAD) or Peripherally Inserted Central Catheter (PICC)? |
PICC |
24 |
2018 |
Catheter-related Complications of Subcutaneous Implantable Venous Access Devices in Breast Cancer Patients. |
--- |
25 |
2018 |
Effects of prolonged flushing interval in totally implantable venous access devices (TIVADs). |
FIs, TIVADs |
26 |
2018 |
Pinch-Off Syndrome, a Rare Complication of Totally Implantable Venous Access Device Implantation: A Case Series and Literature Review. |
POS |
27 |
2018 |
The role of antibiotics in preventing totally implantable venous access device (TIVAD) infections; is there a population that would benefit? |
WBC |
28 |
2018 |
Totally Implantable Venous-Access Device Infection Causing Hematogenous Prosthetic Joint Infection: A Retrospective Case Series. |
PJIs |
29 |
2017 |
Long-term outcomes of totally implantable venous access devices. |
HR, PABSI |
30 |
2017 |
Right or left? Side selection for a totally implantable vascular access device: a randomised observational study. |
--- |
31 |
2016 |
Evaluation of the perceptions and cosmetic satisfaction of breast cancer patients undergoing totally implantable vascular access device (TIVAD) placement. |
TIVADs |
32 |
2016 |
Internal jugular vein versus subclavian vein as the percutaneous insertion site for totally implantable venous access devices: a meta-analysis of comparative studies. |
CI, IJV, OR, RCTs, SCV |
33 |
2016 |
Routine Antibiotic Prophylaxis for Totally Implantable Venous Access Device Placement: Meta-Analysis of 2,154 Patients. |
PRISMA |
34 |
2016 |
Totally implantable vascular access device (TIVAD) placement: a modified technique that takes post-procedure aesthetic aspects into account. |
--- |
35 |
2016 |
Totally Implantable Venous Access Devices in Children Requiring Long-Term Chemotherapy: Analysis of Outcome in 122 Children from a Single Institution. |
--- |
36 |
2015 |
Evaluation of three different techniques for insertion of totally implantable venous access device: A randomized clinical trial. |
IJB, SCB, US, USG |
37 |
2015 |
Is there any effect of first-day usage of a totally implantable venous access device on complications? |
--- |
38 |
2015 |
Retained embolized fragment of totally implantable central venous catheter in right ventricle: it is really necessary to remove? |
--- |
39 |
2015 |
Retrospective evaluation of totally implantable venous access port devices: early and late complications. |
--- |
40 |
2015 |
Review of the radiation exposure during screening of surgically implanted central venous access devices. |
SIVADs |
41 |
2015 |
[Multicenter validation study of a questionnaire assessing patient satisfaction with and acceptance of totally-implanted central venous access devices]. |
--- |
42 |
2014 |
Central venous thrombosis and thrombophilia in cystic fibrosis: A prospective study. |
CF, Doppler-US |
43 |
2014 |
Fast Track ultrasound protocol to detect acute complications after totally implantable venous access device placement. |
--- |
44 |
2014 |
Totally implantable vascular access devices 30 years after the first procedure. What has changed and what is still unsolved? |
US |
45 |
2014 |
Totally implantable venous access devices: retrospective analysis of different insertion techniques and predictors of complications in 796 devices implanted in a single institution. |
--- |
46 |
2013 |
Maintaining patency in totally implantable venous access devices (TIVAD): a time-to-event analysis of different lock irrigation intervals. |
TIVADs |
47 |
2013 |
Morbidity of chemotherapy administration and satisfaction in breast cancer patients: a comparative study of totally implantable venous access device (TIVAD) versus peripheral venous access usage. |
PIVA |
48 |
2013 |
Routine chest X-ray is not mandatory after fluoroscopy-guided totally implantable venous access device insertion. |
--- |
49 |
2013 |
Surgical placement of totally implantable venous access device-an institutional experience. |
GA |
50 |
2013 |
Totally implantable venous access device in children with cancer lead to disfiguring scar. |
mVSS |
51 |
2012 |
Radio-opacity and incidental identified mechanical complications of totally implantable venous access devices placed in the chest. |
--- |
52 |
2012 |
Totally implantable central venous access ports in patients with cystic fibrosis: a multicenter prospective cohort study. |
CF, CFRD |
53 |
2012 |
Totally implanted venous access devices implanted in the saphenous vein. Relation between the reservoir site and comfort/discomfort of the patients. |
--- |
54 |
2012 |
Update on totally implantable venous access devices. |
--- |
55 |
2011 |
Clinical review and analysis of complications of totally implantable venous access devices for chemotherapy. |
--- |
56 |
2011 |
Feasibility and safety of endovascular stripping of totally implantable venous access devices. |
--- |
57 |
2011 |
Intravenous electrocardiography helps inexperienced operators to place totally implantable venous access device more accurately. |
IVECG |
58 |
2011 |
Systematic review: malfunction of totally implantable venous access devices in cancer patients. |
--- |
59 |
2011 |
The role of antibiotic prophylaxis in totally implantable venous access device placement: results of a single-center prospective randomized trial. |
--- |
60 |
2011 |
Ultrasound-assisted percutaneous catheterization of the axillary vein for totally implantable venous access device. |
--- |
61 |
2010 |
Increased use of percutaneous technique for totally implantable venous access devices. Is it real progress? A 27-year comprehensive review on early complications. |
--- |
62 |
2010 |
Outcome of cephalic vein cut-down approach: A safe and feasible approach for totally implantable venous access device placement. |
CVCD |
63 |
2010 |
Sensory perceptions of patients with cancer undergoing surgical insertion of a totally implantable venous access device: a qualitative, exploratory study. |
SIG |
64 |
2009 |
Could antibiotic prophylaxis be not necessary to implant totally implantable venous access devices? Randomized prospective study. |
--- |
65 |
2009 |
Modification of approach for totally implantable venous access device decreases rate of complications. |
EJV, SV |
66 |
2009 |
Skin erosion over totally implanted vascular access devices in children. |
--- |
67 |
2008 |
Seat belt associated central line fracture--a previously unreported complication in cystic fibrosis. |
CF, MVA, RTA, TIVADs |
68 |
2007 |
A comparative study between two central veins for the introduction of totally implantable venous access devices in 1201 cancer patients. |
IJ, SC |
69 |
2007 |
Pulmonary hypertension due to a retained totally implantable venous access device fragment. |
--- |
70 |
2006 |
Infection assessment of totally implanted long-term venous access devices. |
CNS |
71 |
2006 |
The catheter is stuck: complications experienced during removal of a totally implantable venous access device. A single-center study in 200 children. |
--- |
72 |
2005 |
External jugular vein cutdown approach, as a useful alternative, supports the choice of the cephalic vein for totally implantable access device placement. |
CV, EJV |
73 |
2005 |
Prevalence of thrombophilia and catheter-related thrombosis in cystic fibrosis. |
APA, CF |
74 |
2005 |
Subclavian vein stenosis following totally implantable venous access device (TIVAD) implant by percutaneous approach. Case report. |
TIVADs |
75 |
2005 |
Thrombophilia in children with cystic fibrosis. |
CF |
76 |
2005 |
[Assessment of patient's comfort and functioning of a totally implantable venous system placed in the safenous vein]. |
--- |
77 |
2004 |
Acute laryngeal paralysis induced by the migration of a totally implantable venous access device's catheter tip. |
IJV |
78 |
2004 |
Cutaneous bacterial colonization, modalities of chemotherapeutic infusion, and catheter-related bloodstream infection in totally implanted venous access devices. |
CRBI |
79 |
2003 |
[Cephalic vein access for implantable venous access devices. Technique and long-term follow-up]. |
--- |
80 |
2003 |
[Complications with totally implantable venous access device. A retrospective of 116 cases]. |
--- |
81 |
2003 |
[Importance of nursing in the prevention of complications of totally implantable venous access devices]. |
--- |
82 |
2002 |
Totally implanted venous access device removal in interventional radiology. |
IR |
83 |
2001 |
A new technique for insertion of totally implantable venous access devices (TIVAD). |
--- |
84 |
2000 |
[Use of GEE for modeling censored correlated data: application to the study of risk factors for withdrawal of totally implantable vascular access devices in cystic fibrosis]. |
GEE |
85 |
1998 |
Totally implantable venous access devices in cystic fibrosis: complications and patients' opinions. |
--- |
86 |
1996 |
Experience with the Port-A-Cath in sickle cell disease. |
SCD |
87 |
1996 |
Infections associated with totally implantable venous access devices (TIVAD) in human immunodeficiency virus-infected patients. |
--- |
88 |
1996 |
Totally implantable vascular access devices in 131 pediatric oncology patients. |
--- |